Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Slide: 24 of 37

Summary of Benefits (2)

Bone mineral content increased in rhGH-treated patients, but it is not known if this change alters fracture risk and the strength of evidence is low. Percent predicted FEV1 is a good predictor of mortality risk and influences HRQoL reporting. However, moderate-strength evidence indicates that rhGH treatment did not improve this measure.